Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Liquid biopsy with cell free DNA: new horizons for prostate cancer.

Critical reviews in clinical laboratory sciences - 1 Jan 2021

Ponti Giovanni, Maccaferri Monia, Percesepe Antonio, Tomasi Aldo, Ozben Tomris

Abstract excerpt

Although prostate cancer (PCa) is one of the most common tumors in European males, the only minimally invasive diagnostic tool in PCa setup is the determination of PSA in serum. Cell-free DNA (cfDNA) has been demonstrated to be helpful for PCa diagnosis but has not yet been integrated into the clinical setting. This review aims to provide a systematic update of cfDNA and its fragmentation patterns in PCa reported...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cancer Genomics and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell-Free Nucleic Acids

Share to Circulating Tumor DNA

Share to Genetic factors in colorectal cancer

Share to Liquid Biopsy

Share to Mutation

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 32805148
DOI: 10.1080/10408363.2020.1803789

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Liquid biopsy with cell free DNA: new horizons for prostate cancer.PMID 32805148Read ↗

Refined Procedure to Purify and Sequence Circulating Cell-Free DNA in Prostate CancerSemantic proximity Read ↗

Post-Biopsy Cell-Free DNA From Blood: An Open Window on Primary Prostate Cancer Genetics and BiologySemantic proximity Read ↗

Integrative genomic and epigenomic profiling in plasma and urinary cell-free DNA improves early risk stratification of newly diagnosed prostate cancerSemantic proximity Read ↗

Post-biopsy cell-free DNA from blood: an open window on primary prostate cancer genetics and biologySemantic proximity Read ↗

Cell-free DNA concentration and fragment size as a biomarker for prostate cancerSemantic proximity Read ↗

Comparison of androgen receptor mutation detection between plasma extracellular vesicle DNA and cell-free DNA and its relationship to prostate cancer prognosis.Semantic proximity Read ↗

Blood-based liquid biopsy in advanced prostate cancer.Semantic proximity Read ↗

Quantitative analysis of plasma cell-free DNA and its DNA integrity in patients with metastatic prostate cancer using ALU sequenceSemantic proximity Read ↗

Liquid biopsy in prostate cancer: A novel dual biomarker analysis approach integrating circulating tumor cells and circulating tumor DNA data.Semantic proximity Read ↗

Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer.Semantic proximity Read ↗

Cell-free DNA as a biomarker in cancerSemantic proximity Read ↗

Clinical determinants for successful circulating tumor DNA analysis in prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.